在大型动物模型中,MHC II类共享似乎通过链接抑制促进了肠道异位移植的耐受性
M Esad Gunes1, Satyajit Patwardhan1, Sarah Merl1,2
1Columbia Center of Translational Immunology, Columbia University, New York, NY.
Transplantation
|August 21, 2025
概括
在肠道移植中,主要组织相容性复合体 (MHC) II 类等位基因的部分匹配通过捐赠者的调节性T细胞 (Tregs) 促进"分裂耐受性". 这表明移植前的组织类型可以指导耐受性诱导策略.
科学领域:
- 免疫学
- 移植科学
- 调控性T细胞生物学
背景情况:
- 在实现移植耐受性方面,主要组织相容性复合体 (MHC) 的I类和II类匹配作用尚未完全理解.
- 由于肠道的复杂免疫环境,肠道移植 (ITx) 具有独特的挑战.
研究的目的:
- 研究选择性MHC不匹配对ITx在猪模型中的移植耐受性诱导的影响.
- 阐明与MHC兼容性相关的耐受性发展的机制.
主要方法:
- 在不同程度的MHC匹配的猪中进行了正位体ITx:单元型匹配,部分匹配 (II类重叠) 和完全不匹配.
- 在移植后进行免疫抑制并逐渐停止.
- 在体外测试,包括新的粘膜混合淋巴细胞反应,用于分析免疫反应.
主要成果:
- 完全不匹配的植入物没有达到耐受性.
- 部分匹配的移植形成了"分裂耐受性",其特征是通过捐赠者的调节性T细胞 (Tregs) 调节的局部移植接受.
- 型匹配的动物表现出外围Tregs,与捐赠者特异的低反应性和持久的混合基因组,与共享的II类等位基因相关.
结论:
- 主要组织相容性复合体II等位基因的共享,即使是部分共享,也可以促进肠道移植中的T细胞调节性耐受性.
- 这种机制涉及依赖于抗原呈现细胞上同表达的等位基因的相关抑制.
- 这些发现对通过移植前组织类型化改善人类肠道移植的临床耐受性产生重大影响.
相关概念视频
Tissue Transplantation
519
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
519
Cell-mediated Immune Responses
72.4K
Overview
72.4K
Antigens Involved in Adaptive Immunity
667
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
667


